SANA logo

Sana Biotechnology (SANA)

Profile

Full Name

Sana Biotechnology, Inc.

Ticker Symbol

SANA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 4, 2021

Indexes

Not included

Website

http://www.sana.com

Employees

194

Key Details

Price

$1.43(-7.74%)

Market cap

$321.79M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.16(+20.55% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.43
SANA price is $1.43

30-Day Relative Volume

1.13
SANA 30-day relative volume is 1.13

Price Performance

Price Today change

-7.74%
SANA price is down -7.74% today

Price YTD change

-12.27%
SANA price is down -12.27% since January 1st

Price 1-year change

-84.11%
SANA price is down -84.11% year-on-year

Price 3-year change

-83.47%
SANA price is down -83.47% over the past 3 years

Price Range

Price All-time high

$44.60
SANA price is currently -96.79% below its historical high of $44.60

Price 3-year low

$1.26
SANA price is currently +13.49% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$321.79M
SANA market capitalization is $321.79 million

Market cap 3-year change

-80.38%
SANA market capitalization is down -80.38% over the past 3 years

Market cap All-time high

$8.15B
SANA market capitalization is currently -96.05% below its historical high of $8.15 billion

Market cap sector rank

64.91%
SANA market capitalization is higher than 64.91% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.67%
SANA shares outstanding is up +1.67% year-on-year

Shares Outstanding 3-Year Change

+18.68%
SANA shares outstanding is up +18.68% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.82
SANA beta is 1.82

200-day SMA

$3.66
SANA price is currently -60.94% below its 200-day simple moving average

50-day SMA

$2.52
SANA price is currently -43.22% below its 50-day simple moving average

RSI

38.20
SANA 14-day relative strength index is 38.20

Volume

1.13
SANA 30-day relative volume is 1.13

ATR

$0.25
SANA average true range is $0.25

10-day Historical Volatility

164.75%
SANA 10-day historical volatility is 164.75%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
SANA annual revenue value is unknown

Revenue Analysts estimate

-
SANA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
SANA annual revenue 1-year change is unknown

Revenue Sector rank

-
SANA annual revenue is unknown

EPS

EPS

-$1.16
SANA annual earnings per share is -$1.16

EPS Analysts estimate

-$0.88
SANA annual earnings per share is currently +31.73% higher than the consensus analysts' forecast

EPS 1-year change

+20.55%
SANA annual earnings per share is up +20.55% year-on-year

EPS Sector rank

52.77%
SANA annual earnings per share is higher than 52.77% of companies in Healthcare sector

Profit

Gross profit

-
SANA annual gross profit value is unknown

Gross margin

-
SANA annual gross profit margin value is unknown

Operating profit

-$272.72M
SANA annual operating income is -$272.72 million

Operating margin

-
SANA annual operating profit margin value is unknown

Net income

-$266.76M
SANA annual net profit is -$266.76 million

Net margin

-
SANA annual net profit margin value is unknown

Expenses

Total expenses

$272.72M
SANA annual total expenses is $272.72 million

Operating expenses

$272.72M
SANA annual total operating expenses is $272.72 million

Cost of goods sold

-
SANA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$64.04M
SANA annual SGA is $64.04 million

Depreciation and amortization

$17.39M
SANA annual depreciation & amortization is $17.39 million

Interest expense

-
SANA annual interest expense value is unknown

Income tax

-
SANA annual income tax value is unknown

EBIT & EBITDA

EBIT

-$272.72M
SANA annual earnings before interest & taxes is -$272.72 million

EBITDA

-$255.33M
SANA annual EBITDA is -$255.33 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$501.02M
SANA annual total assets is $501.02 million

Non current assets

$340.21M
SANA annual long term assets is $340.21 million

Current assets

$160.81M
SANA annual total current assets is $160.81 million

Cash and cash equivalents

$127.57M
SANA annual cash & cash equivalents is $127.57 million

Accounts receivable

-
SANA annual accounts receivable value is unknown

Inventory

-
SANA annual inventory value is unknown

Liabilities

Total liabilities

$250.52M
SANA annual total liabilities is $250.52 million

Long term liabilities

$205.08M
SANA annual total long term liabilities is $205.08 million

Current liabilities

$45.43M
SANA annual total current liabilities is $45.43 million

Accounts payable

$5.21M
SANA annual accounts payable is $5.21 million

Debt

Total debt

$94.20M
SANA annual total debt is $94.20 million

Total debt 1-year change

-9.51%
SANA annual total debt is down -9.51% year-on-year

Long term debt

$81.66M
SANA annual long term debt is $81.66 million

Short term debt

$12.53M
SANA annual short term debt is $12.53 million

Equity & Capital

Shareholders equity

$250.50M
SANA annual stockholders equity is $250.50 million

Book value

$250.50M
SANA annual book value is $250.50 million

Retained earnings

-$1.60B
SANA annual retained earnings is -$1.60 billion

Working capital

$115.38M
SANA annual working capital is $115.38 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$223.15M
SANA annual cash flow from operations is -$223.15 million

Cash from operations 1-year change

+12%
SANA annual cash flow from operations is up +12% year-on-year

Cash from investing

$17.45M
SANA annual cash flow from investing activities is $17.45 million

Cash from investing 1-year change

-89.85%
SANA annual cash flow from investing activities is down -89.85% year-on-year

Cash from financing

$199.75M
SANA annual cash flow from financing activities is $199.75 million

Cash from financing 1-year change

+531.2%
SANA annual cash flow from financing activities is up +531.2% year-on-year

CAPEX

CAPEX

-
SANA annual capital expenditures value is unknown

CAPEX 1-year change

-
SANA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$256.58M
SANA annual free cash flow is -$256.58 million

Free cash flow 1-year change

+6.22%
SANA annual free cash flow is up +6.22% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
SANA annual gross profit margin value is unknown

Operating margin

-
SANA annual operating profit margin value is unknown

Net margin

-
SANA annual net profit margin value is unknown

ROA & ROE

ROA

-53.24%
SANA annual return on assets is -53.24%

ROE

-106.49%
SANA annual return on equity is -106.49%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SANA price to earnings ratio value is unknown

PE ratio Sector rank

-
SANA price to earnings ratio is unknown

PB Ratio

PB ratio

1.28
SANA price to book ratio is 1.28

PB ratio Sector rank

51.73%
SANA price to book ratio is higher than 51.73% of companies in Healthcare sector

PS Ratio

PS ratio

-
SANA price to sales ratio value is unknown

PS ratio Sector rank

-
SANA price to sales ratio is unknown

Enterprise value

Enterprise value

$288.42M
SANA enterprise value is $288.42 million

Enterprise value Sector rank

63.73%
SANA enterprise value is higher than 63.73% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.13
SANA EV/EBITDA is -1.13

EV/EBITDA Sector rank

39.41%
SANA EV/EBITDA is higher than 39.41% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.54
SANA annual current ratio is 3.54

Quick ratio

-
SANA annual quick ratio value is unknown

Leverage

Debt to equity

0.38
SANA annual debt to equity ratio is 0.38

Interest coverage ratio

-
SANA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
SANA piotroski f-score value is unknown

Altman Z-Score

-
SANA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 18, 25 HC Wainwright & Co.
Buy
Mar 18, 25 Citizens Capital Markets
Market Outperform
Mar 14, 25 Jefferies
Buy
Jan 8, 25 TD Cowen
Buy
Jan 8, 25 HC Wainwright & Co.
Buy
Nov 27, 24 HC Wainwright & Co.
Buy
Nov 11, 24 HC Wainwright & Co.
Buy
Nov 5, 24 JMP Securities
Market Perform
Nov 5, 24 HC Wainwright & Co.
Buy
Aug 9, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

STOK logo
Stoke Therapeutics (STOK)
Upstream Bio (UPB)
KMDA logo
Kamada (KMDA)
Maze Therapeutics (MAZE)
VREX logo
Varex Imaging (VREX)
ETON logo
Eton Pharmaceuticals (ETON)
ERAS logo
Erasca (ERAS)
SMLR logo
Semler Scientific (SMLR)
CLPT logo
ClearPoint Neuro (CLPT)
  • What is the ticker symbol for Sana Biotechnology?
  • Does Sana Biotechnology pay dividends?
  • What sector is Sana Biotechnology in?
  • What industry is Sana Biotechnology in?
  • What country is Sana Biotechnology based in?
  • When did Sana Biotechnology go public?
  • Is Sana Biotechnology in the S&P 500?
  • Is Sana Biotechnology in the NASDAQ 100?
  • Is Sana Biotechnology in the Dow Jones?
  • When was Sana Biotechnology's last earnings report?
  • When does Sana Biotechnology report earnings?
  • Should I buy Sana Biotechnology stock now?

What is the ticker symbol for Sana Biotechnology?

The ticker symbol for Sana Biotechnology is NASDAQ:SANA

Does Sana Biotechnology pay dividends?

No, Sana Biotechnology does not pay dividends

What sector is Sana Biotechnology in?

Sana Biotechnology is in the Healthcare sector

What industry is Sana Biotechnology in?

Sana Biotechnology is in the Biotechnology industry

What country is Sana Biotechnology based in?

Sana Biotechnology is headquartered in United States

When did Sana Biotechnology go public?

Sana Biotechnology's initial public offering (IPO) was on February 4, 2021

Is Sana Biotechnology in the S&P 500?

No, Sana Biotechnology is not included in the S&P 500 index

Is Sana Biotechnology in the NASDAQ 100?

No, Sana Biotechnology is not included in the NASDAQ 100 index

Is Sana Biotechnology in the Dow Jones?

No, Sana Biotechnology is not included in the Dow Jones index

When was Sana Biotechnology's last earnings report?

Sana Biotechnology's most recent earnings report was on Mar 17, 2025

When does Sana Biotechnology report earnings?

The next expected earnings date for Sana Biotechnology is May 8, 2025

Should I buy Sana Biotechnology stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page